Zobrazeno 1 - 10
of 195
pro vyhledávání: '"Gus, Gazzard"'
Autor:
Nancy M. Holekamp, Manejeh Yaqub, Shrirang V. Ranade, Ronald A. Cantrell, Sheena Singh, Gus Gazzard
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 9, Pp 2303-2329 (2024)
Abstract Objectives To determine whether the types and rates of post-surgical complications associated with the Port Delivery System with ranibizumab (PDS) are comparable with those reported for other ocular implants that cross the sclera. Methods Sy
Externí odkaz:
https://doaj.org/article/63a3efc1f3b54d1a99c2b0af0745d82f
Autor:
James Morgan, David P Crabb, Augusto Azuara-Blanco, Yemisi Takwoingi, David Wright, Gus Gazzard, Rodolfo Hernández, Verity Watson, Anthony King, Hangjian Wu
Publikováno v:
BMJ Open Ophthalmology, Vol 9, Iss 1 (2024)
Background/Aims To assess the cost-effectiveness of making treatment decisions for patients with ocular hypertension (OHT) based on a risk prediction (RP) tool in the United Kingdom.Methods A discrete event simulation model was constructed to compare
Externí odkaz:
https://doaj.org/article/6f2afe0bbb7e4e9eb643b4eeaddc7230
Publikováno v:
BMJ Open, Vol 14, Iss 5 (2024)
Objectives To assess whether patients from minority ethnic groups have different perceptions about the quality-of-life outcomes that matter most to them.Design Cross-sectional observational study.Setting High volume eye centres serving the most ethni
Externí odkaz:
https://doaj.org/article/2d845e3fe8ec461bbf61ab5bb3b93d9a
Autor:
Giovanni Montesano, Giovanni Ometto, Iqbal Ike K. Ahmed, Pradeep Y. Ramulu, David F. Chang, David P. Crabb, Gus Gazzard
Publikováno v:
American Journal of Ophthalmology. 251:143-155
Autor:
Heiko Philippin, MD, Einoti Matayan, MMed, Karin M Knoll, MD, Edith Macha, Pharm Tech, Sia Mbishi, BSc, Andrew Makupa, MMed, Cristóvão Matsinhe, MMed, Vasco da Gama, MMed, Mario Monjane, MMed, Awum Joyce Ncheda, MMed, Francisco Alcides Mulobuana, MMed, Elisante Muna, MMed, Nelly Fopoussi, MMed, Gus Gazzard, ProfFRCOphth, Ana Patricia Marques, PhD, Peter Shah, ProfFRCOphth, David Macleod, PhD, William U Makupa, MMed, Matthew J Burton, ProfPhD
Publikováno v:
The Lancet Global Health, Vol 9, Iss 11, Pp e1589-e1599 (2021)
Summary: Background: Glaucoma is a major cause of sight loss worldwide, with the highest regional prevalence and incidence reported in Africa. The most common low-cost treatment used to control glaucoma is long-term timolol eye drops. However, low ad
Externí odkaz:
https://doaj.org/article/cb9b8403ea26444c81800d7f9d9c086e
Autor:
Augusto Azuara-Blanco, Aaron Carlisle, Matthew O'Donnell, Hari Jayaram, Gus Gazzard, Daniel F.P. Larkin, Louisa Wickham, Noemi Lois
Publikováno v:
Azuara-Blanco, A, Carlisle, A, O'Donnell, M, Jayaram, H, Gazzard, G, Larkin, D F P, Wickham, L & Lois, N 2023, ' Design and conduct of randomized clinical trials evaluating surgical innovations in ophthalmology: a systematic review ', American Journal of Ophthalmology, vol. 248, pp. 164-175 . https://doi.org/10.1016/j.ajo.2022.12.010
PurposeSurgical innovations are necessary to improve patient care. After an initial exploratory phase novel surgical technique should be compared with alternative options or standard care in randomized clinical trials (RCTs). However surgical RCTs ha
Autor:
Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, Mariam Adeleke, Victoria Vickerstaff, Gareth Ambler, Rachael Hunter, Catey Bunce, Neil Nathwani, Keith Barton
Publikováno v:
Ophthalmology. 130:139-151
Publikováno v:
BMJ Open Ophthalmology, Vol 5, Iss 1 (2020)
Introduction In the UK, the National Institute for Health and Clinical Excellence are amending guidelines to support use of selective laser trabeculoplasty (SLT) as a first-line treatment for patients with glaucoma and ocular hypertension. The proced
Externí odkaz:
https://doaj.org/article/16323ff71a1b4036a8ca0bec5ce27e7d
Autor:
Iqbal Ike K. Ahmed, Ticiana De Francesco, Douglas Rhee, Cathleen McCabe, Brian Flowers, Gus Gazzard, Thomas W. Samuelson, Kuldev Singh
Publikováno v:
Ophthalmology. 129:742-751
To present the 5-year results of the HORIZON trial comparing cataract surgery (CS) combined with an intracanalicular microstent with CS alone.Prospective, multicenter, controlled randomized clinical trial.Patients with cataract and primary open-angle
Publikováno v:
Eye.
Background/Objectives Recent clinical trials in glaucoma have used patient-reported outcome measures (PROMs) of health-related quality of life to evaluate interventions. However, existing PROMs may not be sufficiently sensitive to capture changes in